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Abstract
Although the functional consequences of mitochondrial DNA (mtDNA) genetic backgrounds (haplotypes, haplogroups)
have been demonstrated by both disease association studies and cell culture experiments, it is not clear which of the
mutations within the haplogroup carry functional implications and which are ‘‘evolutionary silent hitchhikers’’. We set forth
to study the functionality of haplogroup-defining mutations within the mtDNA transcription/replication regulatory region
by in vitro transcription, hypothesizing that haplogroup-defining mutations occurring within regulatory motifs of mtDNA
could affect these processes. We thus screened .2500 complete human mtDNAs representing all major populations
worldwide for natural variation in experimentally established protein binding sites and regulatory regions comprising a total
of 241 bp in each mtDNA. Our screen revealed 77/241 sites showing point mutations that could be divided into non-fixed
(57/77, 74%) and haplogroup/sub-haplogroup-defining changes (i.e., population fixed changes, 20/77, 26%). The variant
defining Caucasian haplogroup J (C295T) increased the binding of TFAM (Electro Mobility Shift Assay) and the capacity of in
vitro L-strand transcription, especially of a shorter transcript that maps immediately upstream of conserved sequence block
1 (CSB1), a region associated with RNA priming of mtDNA replication. Consistent with this finding, cybrids (i.e., cells sharing
the same nuclear genetic background but differing in their mtDNA backgrounds) harboring haplogroup J mtDNA had a .2
fold increase in mtDNA copy number, as compared to cybrids containing haplogroup H, with no apparent differences in
steady state levels of mtDNA-encoded transcripts. Hence, a haplogroup J regulatory region mutation affects mtDNA
replication or stability, which may partially account for the phenotypic impact of this haplogroup. Our analysis thus
demonstrates, for the first time, the functional impact of particular mtDNA haplogroup-defining control region mutations,
paving the path towards assessing the functionality of both fixed and un-fixed genetic variants in the mitochondrial
genome.
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Introduction
Mitochondria are the major sources for cellular energy, through
the process of oxidative phosphorylation (OXPHOS), and thus
play a central role in cell life and death. Since mitochondrial DNA
(mtDNA) encodes 13 essential proteins of the energy production
apparatus and 24 key factors of their translation machinery (i.e. 22
tRNAs and 2 rRNAs) it is not surprising that numerous association
studies have demonstrated the involvement of mtDNA genetic
backgrounds (haplotypes, haplogroups) in complex human disor-
ders as well as in selective events that transpired during human
evolution [1]. Such implied functional potential of natural mtDNA
variants has gained recent experimental support in human and
murine cytoplasmic hybrids (cybrids) [2,3]. Further support was
provided by back-cross experiments in Drosophila and rat as well
as by inter-populations crosses in Tigriopus Americana revealing that
the interaction of mtDNA with the nuclear genetic background is
under selective constraint [4,5,6]. This implies that mtDNA
variants underlying population divergence have phenotypic
consequences. Nevertheless, all the above mentioned studies
analyzed complete haplotypes, thus masking the effects of single
nucleotide changes within haplogroups.
How thus can one isolate the functional effect of specific
mutations from their linked genetic background? Previously, we
considered evolutionary sequence conservation to assess the
functional importance of all common genetic variants in coding
mtDNA, following the logic, that the more conserved the
nucleotide position among species, the higher the functional
importance [7,8,9]. This approach revealed that certain mutations
that define human mtDNA lineages alter nucleotide positions to
an equivalent degree of conservation as disease-causing mutations.
Although predicting functional potential for coding region
mutations, this observation cannot currently be tested experimen-
tally, largely due to technical difficulties hampering site-directed
mutagenesis in human mtDNA. This obstacle could, however, be
partially overcome by cloning mtDNA-encoded genes, changing
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ribosomes and then re-direct the nascent protein products to the
mitochondria by exploiting introduced mitochondrial targeting
sequences [10,11,12]. The success of this approach is limited to
only certain mtDNA-encoded proteins. By contrast, allotopic
expression of some mtDNA-encoded proteins was toxic to cells
[11]. As such, this approach was not used to study the functionality
of common variants. Moreover, haplogroup-defining mtDNA
variants are mapped to protein and RNA-coding genes, as well as
to non-coding regions, thus calling for alternative approaches to
assess the functionality of non-coding mtDNA haplogroup-
defining mutations.
In contrast to the mtDNA coding region, most mitochondrial
regulatory elements (excluding the three conserved sequence
blocks, CSBs) are subjected to many back-mutations [13,14].
Moreover, sequences of mtDNA regulatory elements are much
more flexible over the evolutionary time scale. Nevertheless,
alterations of certain nucleotide positions with relatively poor
evolutionary conservation were associated with phenotypes [15]
suggesting that attributes other than evolutionary conservation
should be considered to assess the functionality of mtDNA control
region changes.
We hypothesized that certain sequence elements across the
mitochondrial control region, not necessarily those with high inter-
species conservation, are subjected to natural selection within
populations. To test this hypothesis we chose to assess the
functional potential of genetic variants in the mtDNA control
region within sites harboring accepted functionality. mtDNA
harbors sequence motifs that are recognized by members of the
mtDNA transcription and replication machineries, all of which are
encoded by the nuclear genome [16]. Such proteins bind
particular sequences in the mtDNA promoters and origins of
replication (Figure 1). Specifically, mitochondrial transcription
factor A (TFAM) binds 4 mtDNA sites, two of which lay within the
promoter region and two which lay down-stream to the L-strand
promoter. The OXBOX-REBOX transcription factor binds a
motif in CSB3 [14], while mitochondrial transcription termination
factor (MTERF) recognizes a motif within tRNA-Leu (nucleotide
positions 3232–3256) [17]. The termination-associated sequence
(TAS) is bound by a specific protein that has yet to be isolated [18]
and, finally, mtDNA origin of the light strand (Ori-L) is bound by
specific factors (Joseph Shlomai, personal communication).
Here, we demonstrate that some single base changes that were
fixed within TFAM binding sites during human evolution alter
protein binding efficiency. One of these changes not only altered
TFAM binding efficiency but also increased the efficiency of in vitro
transcription by ,2.5 fold and was associated with more than 2
fold increase in mtDNA copy numbers in mtDNA-less cell lines
(rho-0 cells) repopulated with the mtDNA from haplogroup J. The
interpretations of these results within the framework of under-
standing the implications of the phenotypic effects of haplogroup J
are discussed.
Author Summary
Mitochondria, the ‘power plant’ of the cell, have their own
distinct genome (mtDNA), whose sequence varies among
individuals around the globe. This variation, which was
formed by the accumulation of mutations (variants) during
the course of evolution, appears to alter the susceptibility
to common complex diseases (such as Parkinson’s disease
and diabetes). However, since the accumulation of mtDNA
mutations over time results in the formation of new
combinations (genetic backgrounds), it is not clear which
of the mutations are functional and which are ‘‘evolution-
ary silent hitchhikers’’. Thus we aimed at assessing the
functionality of mtDNA genetic variants, focusing on
variants within the mtDNA regulatory region, hypothesiz-
ing that they could affect mtDNA activity and mainte-
nance. We found that a variant defining mtDNA genetic
background ‘J’ significantly increased the transcriptional
efficiency and elevated mtDNA copy numbers in cells, as
compared to other genetic backgrounds. Hence, mtDNA
regulatory region variants can affect mtDNA maintenance,
which may partially account for the involvement of this
genetic background in disease susceptibility. Our analysis
demonstrates, for the first time, the functional impact of a
particular mtDNA variant that was fixed during evolution.
Moreover, our findings underline the functionality of
mtDNA variants in the evolutionary variable regulatory
region.
Figure 1. Schematic representation of the D-loop regulatory region. The names of regulatory motifs are indicated: the three conserved
sequence blocks (CSB1, CSB2, and CSB3), light-strand promoter (LSP), heavy-strand promoter (HSP), the conserved termination-associated sequence
(TAS), and origin of H-strand DNA replication (OH). Blue rectangles represent TFAM-binding sites and the red rectangle represents the mTERF binding
site. The arrows pointing left and right show transcription orientation of H (H1 and H2) and L strands, respectively. The location of ribosomal RNA
genes (12S and 16S) and the genes encoding tRNAs for phenylalanine, valine and leucine (F, V, and L, respectively) is indicated.
doi:10.1371/journal.pgen.1000474.g001
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We have screened more than 2500 whole mtDNA sequences
from various human populations worldwide (http://www.genpat.
uu.se/mtDB/) for natural variants in experimentally established
protein binding sites and regulatory regions in the mtDNA control
region (Table 1). These include recognition sites for mitochondrial
transcription factor A (TFAM) and transcription termination
factor (mTERF), the conserved sequence blocks (CSBs), and
mitochondrial recognition sites for proteins of the replication
machinery (TAS and origin of replication of the light strand - OL),
comprising a total of 241 bp in each mtDNA. This screen
identified that 77/241 of the total screened sites harbored
polymorphic point mutations which can be divided into non-fixed
changes (57/77, 74%) and haplogroups/sub-haplogroup-defining
changes (i.e. population-fixed changes), comprising 20/77 (26%) of
the variable nucleotide positions.
To assess the evolutionary conservation of the tested control
region elements we have aligned the mitochondrial DNA
(mtDNA) D-loop sequences of primates and other available
mammalian sequences in each such sites (see Materials and
Methods). Only four protein-binding sites described in human
mtDNA gave trustworthy alignment (i.e. CSB1, CSB3, MTERF
and OriL) and were, therefore, termed ‘highly conserved sites’
(HSS). The rest of our studied sites were either aligned only among
humans and the great apes (i.e. chimpanzee, gorilla and
orangutan) or within some primates, and were therefore regarded
as ‘low conserved sites’ (LSS). It is important to note that CSB2
was excluded from the analysis as it is mapped to human mtDNA
nucleotide positions 299–313 which mainly comprise a cytosine-
tract prone to frequent insertions and deletions in humans, the
frequency of which is hard to compute. We next documented the
minimum number of changes that had occurred at each nucleotide
position during mammalian evolution. Accordingly, nucleotide
positions at HSS sites (n=100) were divided into highly conserved
positions, i.e. completely conserved positions (n=54) and
changeable positions (n=46). While screening for human variants,
we noticed a highly significant under-representation of variants
within the highly conserved nucleotide positions (4/54), as
compared to the evolutionary changed positions (16/46) (Fisher
exact test, p=0.0009). Thus, the more conserved the nucleotide
position the less variable it is.
The LSS sites also showed a pattern of variability, with most
nucleotides being invariable and most of the un-conserved
nucleotide positions undergoing small number of changes in
humans (Table 1). We believe that this pattern is, in fact, a
reflection of variability in the functional importance of LSS
positions, i.e. some nucleotide positions in these sites are
functionally more important than others.
Haplogroup J-defining mtDNA polymorphism alters
TFAM binding and in vitro transcription
As the first step towards experimentally assessing the functional
potential of haplogroup-defining mutations (fixed mutations), we
employed Electrophoresis Mobility Shift Analysis (EMSA).
Specifically, we tested for the effect of transition variants defining
Caucasian haplogroup J (C295T) and a sub-haplogroup of J, J1b2
Table 1. Natural genetic variation in selected mtDNA regulatory elements.
Element Total number 0 changes 1 change 2 changes 3 changes 4 changes $5 changes Fixation events*
CSB I (213–235) 23 14 225,226,235 - 227 215 214,217,228,234 217-U5b
225-X
227-V1, W, X
228-J1c, R31
235-A
CSB II (299–315) 17 12 308,309,315 - - - 310,311 -
CSB III (345–362) 18 13 345,351,357,361 348 - - - -
Ori L (5730–5760) 31 27 5741,5746 5747 5744 - - 5744- B
TFAM (233–260) 28 11 235,237,241,242,
243,248,250,255
246,252, 260 239,249,257 247 234,236 235-A
247-L0/L1
242-J1b
250-I
260-G2
TFAM (276–303) 28 20 281,282,285,291,298 280,284,295,297 - 279 - 280-D4
285-U1
295-J
297-L1
TFAM (418–445) 28 25 418,431 - - 437 - 431-D4
TFAM (523–551) 29 17 527,530,533,534,
537,539,545, 547,549
546,548 - - - -
TAS (16158–16172 15 3 16158,16160,16171 16163 16164,16170 16166 16162
16167
16168
16169
16172
16162-F1/H1
16163-T1
16164-D5
16169-U5b
16172-F1/N9a/U6/
J4/I2
mTERF (3232–3256) 25 23 3253,3254 - - - - -
The columns represent the number of times that mutation events (change) occurred in a given nucleotide position.
*represents fixed changes - mutations that were represented in more than 5 different mtDNA sequences belonging to the same phylogenetic branch (lineage,
haplogroup). Letters within the ‘Fixation events’ column correspond to distinct human mtDNA haplogroups.
doi:10.1371/journal.pgen.1000474.t001
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the four TFAM-binding sites previously mapped by footprinting
human mtDNA [19,20]. EMSA analysis of double-stranded
oligonucleotides spanning each of the two different TFAM
binding sites, revealed increased TFAM binding to the C295T
variant (Figure 2), but no significant difference with C242T variant
(data not shown). In the case of the C295T variant, this increase in
binding was observed at multiple different TFAM to DNA ratios
(10/1 and 25/1 molar ratios are shown in Figure 2). These results
raised the question of whether the C295T variant could affect
mtDNA transcription. To test for this possibility, an mtDNA
fragment spanning nucleotide positions 184–628 was PCR
amplified using DNA samples corresponding to haplogroup J
(harboring the C295T variant), haplogroup J1b2 (harboring both
the C295T and C242T variants) and haplogroup H (harboring
neither of these variants) as templates. The resulting PCR products
were cloned and then utilized as templates in in vitro mitochondrial
run-off transcription assays using partially purified mitochondrial
lysates as a source of POLRMT and transcription factors [21].
The efficiency of light-strand promoter-driven transcription was
,2.5 fold greater from the two haplogroup J templates (J, J1b2)
than that of the haplogroup H fragment (H) (Figure 3), providing
direct evidence for the functional potential of naturally occurring
genetic variants in the human mtDNA regulatory region. Notably,
the J1b2 construct showed increased transcription activity,
although its additional mutation (C242T) did not significantly
affect TFAM binding (data not shown), suggesting that the more
functional variant is C295T that defines haplogroup J as a whole.
Interestingly, the transcription assay produced two major
products, namely a ,230-nt, full-length transcript and a shorter
,160-nt transcript that maps to just upstream of CSB1.
mtDNA copy number is elevated in haplogroup J cybrids
We reasoned that our in vitro transcription results may not only
reflect an effect of haplogroup J mutations on mtDNA transcrip-
tion but also on replication, as these two processes are coupled in
the mitochondria (reviewed in: [16]). Thus, in order to provide
more clues to the physiological importance of our in vitro
transcription findings, we assessed the effects of haplogroup J
mutations on both mtDNA transcript levels (Figure 4) and mtDNA
copy numbers (Figure 5) by real time PCR. To reduce variance in
our measurements due to the expected effect of nuclear genetic
factors, we performed our experiments in cytoplasmic hybrids
(cybrids) carrying mtDNAs of haplogroup J (2 independent
Figure 2. Increased TFAM binding to oligonucleotide probes harboring the C295T mtDNA variant. A. EMSA analysis of TFAM binding to
double-stranded oligonucleotide probes containing the C295T mtDNA variant compared to its ‘‘wild-type’’ control (wt-295). Shown are
autoradiograms of representative EMSA gels performed at a 10:1 (TFAM 106) and 25:1 (TFAM 256) TFAM:probe molar ratio. The locations of the free
and TFAM-bound (shifted) probe are indicated. B. Graphical representation and statistical analysis of the gels in A. The data of binding in the C295T
variant is normalized to that of the wt-295, which was given a value of 1.0. The mean+/2one standard deviation (error bars) is shown as is the
corresponding p-value.
doi:10.1371/journal.pgen.1000474.g002
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schematic map of the mtDNA templates used in the run-off in vitro transcription assay, with the TFAM-binding sites (striped rectangles), light-strand
promoter (LSP, bent arrow), and the location of the 242 and 295 variants (arrows) indicated. B. A representative in vitro transcription reaction using
templates containing the indicated mtDNA variants. Equal amounts of the linear mtDNA templates (ethidium bromide-stained at the bottom) were
used in the in vitro transcription assay with a partially purified POLRMT (i.e. mtRNA polymerase) fraction from HeLa cells. The 223-nt full-length run-off
transcript and a second major, shorter transcript of ,160 nt (see Discussion) are indicated. Quantification of the 223-nt, full-length transcript and the
,160-nt truncated product from multiple independent experiments is shown in C. and D., respectively. Both mutant templates showed a trend
toward increased LSP transcription activity when either the full-length or shorter product was analyzed, but only in the case of shorter, ,160
transcript from the haplogroup J template (C295T) was this difference statistically significant (p-value 0.034).
doi:10.1371/journal.pgen.1000474.g003
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ND1 and ND4L) exhibited reduced steady state levels in only one
of the haplogroup J cybrids (designated 3861), whereas the other
H- and L-strand transcripts showed no significance difference
among the tested cybrids (Figure 4). Since steady state levels of
mRNA reflect a combined effect of transcription and post-
transcriptional regulation and since ND1 and ND4L are co-
transcribed along with 10 H- strand genes (namely ND2-ND5,
CO1-3, ATP6,8), the levels of which did not differ, we interpreted
the lower levels of ND1 and ND4L in the 3861 cybrid as reflecting
a post-transcriptional effect specific to this cybrid.
However, when the mtDNA copy number was assessed in the
panel of cybrids, both haplogroup J cybrids had more than twice
as many mtDNAs than did any of the haplogroup H cybrids
(Figure 5). Since all cybrids were generated using the same Rho-0
cells (Wal-2A) and were grown under the same conditions,
differences in the mtDNA copy numbers should reflect differences
in the replication capacity of the different mtDNA haplotypes.
Discussion
Our results reveal that some genetic variants that became fixed
during human evolution affect protein binding to mtDNA.
Moreover, a point variant in a TFAM binding-site (C295T)
increased in vitro transcription ,2.5 fold. These findings support
the view that some evolutionarily fixed mtDNA variants lead to
functional consequences. The C295T TFAM binding-site variant
did not clearly align with other mammalian sequences, other than
those of the great apes (humans, chimpanzees, gorillas and
orangutans). Nevertheless, the C295T nucleotide position under-
went only a single fixation event during human phylogeny in the
branch leading to haplogroup J, suggesting that, although poorly
conserved, the low human variability at this nucleotide position is
in line with its functional potential. We thus suggest that the degree
of variability of a nucleotide position within humans may serve as
a clue for functionality. To experimentally test for the generality of
this prediction the functionality of additional variable nucleotide
positions should be tested.
Four TFAM-binding sites have been mapped in the human
mitochondrial genome by DNA footprinting, two of which are
important for transcription and are located between the heavy and
light strand promoters. The importance of the other two binding
sites, localized downstream to the light strand promoter is not
known (Figure 1). The altered TFAM binding, as well as the
altered in vitro transcription capacity of the C295T variant
Figure 4. Relative steady-state levels of mtDNA transcripts in cybrids harboring different mtDNA haplogroups. Each color represents
the transcription level estimated by real time quantitative PCR (see Materials and Methods) for mtDNA-encoded genes in the mentioned cybrids.
Briefly, the measured transcripts levels were normalized to the geometric mean of the three housekeeping genes: GAPDH, b-Actin and b2
microglobulin. Cybrids haplogroup assignment was verified by PCR RFLP of selected polymorphic sites and sequencing and HVR1 and HVR2: cybrids
3861 and 1106 belong to haplogroup J1 and J1b2, respectively, while cybrids CB, LR, NN, SB and TL belong to haplogroup H. Notice that the
transcript level of ND1 and ND4L genes were significantly lower in one of the haplogroup J1 cybrids (3861), and that the ND3 transcript level was
lower in one of haplogroup H transcripts (NN).
doi:10.1371/journal.pgen.1000474.g004
Figure 5. Increased mtDNA copy number in haplogroup J
cybrids compared to haplogroup H cybrids. The copy number of
mtDNA was measured using an mtDNA marker (ND2) and a nuclear
DNA marker (18S rRNA gene). Data were obtained from three
independent measurements for each of the tested cybrids, 2 of
haplogroup J and 5 from haplogroup H. Standard deviation is shown
for the mtDNA/nDNA ratios obtained from haplogroup J and
haplogroup H cybrids.
doi:10.1371/journal.pgen.1000474.g005
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the role of this site in mitochondrial transcription. To our
knowledge, this is the first indication that TFAM binding
downstream of the mtDNA promoter might influence transcrip-
tion, possibly through a more complex configuration of the
promoter or by modulating mtDNA wrapping by TFAM, as
previously suggested [16].
The tested variants define known mtDNA haplogroups,
namely Caucasian haplogroup J and a sub-group of haplogroup
J (J1b2). Haplogroup J was previously associated with several
complex phenotypes such as Parkinson’s disease and longevity
(reviewed in: [1] as well as with the tendency of type II diabetes
patients to develop complications [22]. In addition, haplogroup J
increases the penetrance of some mtDNA mutations causing the
eye disorder, LHON (Leber Hereditary Optic Neuropathy).
Since the C295T variant defines haplogroup J and was not fixed
in any other human mtDNA lineage, it is possible that the
observed functional effect can be partially attributed to its
phenotypic effect. Since other mtDNA haplogroups have been
associated with various health conditions, further analysis of
haplogroup-defining variants will be revealing with regard to
their impact on mitochondrial function and their potential health
consequences.
In addition to the ,230-nt, full-length transcription product
expected in the run-off transcription assay, we observed a
shorter ,160-nt transcript (Figure 3) that extends to between
CSB2 and CSB1, but closer to CSB1. The nature of this
product is unclear, but it could be due to pausing or
premature termination of transcription, processing of the
transcript by RNAse [23] or due to a physiologically irrelevant
nuclease activity in the extract used. Less than full-length
products have been observed previously in human mitochon-
drial in vitro transcription assays using recombinant transcrip-
tion components [24], however the main products observed in
that study cluster near CSB2 not CSB1. Since the region
surrounding CSB1 and CSB2 has been implicated in various
aspects of transcriptional priming of mtDNA replication
[24,25,26], and given the involvement of TFAM in mitochon-
drial transcription and replication [16], it is quite possible that,
in addition to its effects on transcription documented herein,
the C295T variant also could impact mtDNA replication
efficiency. Using T7-based in vitro transcription experiment, a
length polymorphism in mtDNA positions 303–315 was
suggested to affect human mitochondrial transcription [27].
The elevated mtDNA copy number in haplogroups J versus H
cybrids support the possibly increased replication capacity of
haplogroups J. Since haplogroup J was associated with
successful longevity in some European populations, and since
mtDNA copy numbers are reduced over age, one can
speculate that the elevated mtDNA copy numbers in
haplogroup J may be one of the factors mediating the
phenotypic effects observed for this haplogroup.
The increase in mtDNA copy number but not transcript
levels in haplogroup J, as opposed to haplogroup H cybrids,
raise the question of why differences in transcript levels were
only observed cell-free in vitro transcription. Measurements of
mtDNA transcript levels by real time PCR reflect the steady
state level of mRNA products, which is affected by both
transcriptional and post-transcriptional regulation. Therefore, it
is still possible that direct measurement of transcription level in
organello will reflect in vitro transcription differences between
haplogroups J and H. Alternatively, it has recently been shown
that increased copy numbers do not necessarily lead to
increased transcription [28], suggesting that our in vitro
transcription results reflect differences in replication rather
than transcription, as discussed above.
Our experiments demonstrate the effects of specific point
mutations in the mtDNA in an in vitro transcription assay. A major
obstacle interfering with the analysis of specific mtDNA mutations
is the current inability to perform site-directed mutagenesis within
mtDNA. This could be partially overcome by mitochondrial
import of mtDNA-encoded genes genetically engineering to be
coded according to the cytoplasmic genetic code. Such re-coded
mtDNA genes can be generated with or without the desired
mutation. Indeed, this approach was successfully adopted for some
mtDNA-encoded proteins (e.g. ATP6, ATP8, ND4 and ND2) but
less successful with most proteins, implying limitations for this
approach [10,11,12]. Such experiments are further complicated
by the need to express the desired mutated mtDNA gene in cells
not expressing the endogenous gene, a scenario currently available
solely with natural disease-associated mutants. In contrast to
coding region mutations, our experiments demonstrate that the
effects of non-coding mtDNA mutations can be tested individually
in cell-free systems.
In summary, our analysis sheds light on the functional effect of
naturally occurring variants in the mtDNA control region and
suggests that such variants contribute to the phenotypic impact of
mitochondrial DNA haplogroups.
Materials and Methods
PCR and cloning of mtDNA control region fragments for
in vitro transcription
DNA from healthy individuals previously assigned to hap-
logroups H, J1 and J1b2 [29], one sample of each, was used as a
template for PCR amplification of an mtDNA fragment
encompassing nucleotide positions 184–628 (using a forward
primer: 59GGCGAACATACTTACTAAAGTG 39 and a reverse
primer: 59GCCCGTCTAAACATTTTCAG 39). The PCR
products were purified using the Wizard SV Gel and PCR
Clean-up system (Promega) according to the manufacturer’s
protocol and then separately cloned into the pGEM T-vector
(Invitrogen) using a ligation kit (Roche). The ligated products were
transformed into E. coli strain DH5a by heat shock and ampicilin-
resistant clones were isolated. Plasmid DNA harboring each of the
cloned fragments was isolated and served as templates in an in vitro
mitochondrial run-off transcription assay (see below).
Electrophoretic mobility shift assays (EMSA)
Oligonucleotides corresponding to wild-type or mutant TFAM
binding sites (Table 2) were annealed, followed by 59 end
labeling with Polynucleotide Kinase (NEB). Labeled DNA
probes (3 nM) were incubated with varying amounts of TFAM
protein (75 nM and 30 nM) for 30 minutes at room temperature
in 10 mM Tris-HCL (pH 7.5), 10 mM KCl, 1 mM DTT, 1 mM
EDTA, and 6% Glycerol. Free and TFAM-bound probes were
then immediately separated on a 5% non-denaturing polyacryl-
amide gel at 150 V for 75 minutes in 0.56 TBE at room
temperature. Gels were then dried, exposed to x-ray film and
bands quantified using Quantity One 4.5.0 (BioRad) imaging
software.
In vitro transcription assay
Mitochondrial run-off transcription reactions were performed
[21] using different mtDNA promoter-containing templates.
PCR products corresponding to nucleotides 184–628 of human
mtDNA and harboring mutations defining either haplogroup J,
J1b2 or the Cambridge Reference Sequence (CRS) [30] were
mtDNA Variants, Transcription and Replication
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plasmid with EcoR1 resulted in the formation of a linear
transcription template from which specific initiation from the
LSP promoter resulted in transcripts 223 nucleotides in length.
Individual reaction mixtures (25 ml) contained 36 mgo fEcoRI-
digested template, 10 mM Tris-Cl, pH 8.0, 10 mM MgCl2,
1 mM dithiothreitol, 100 mg/ml bovine serum albumin, 400 mM
ATP, 150 mM CTP and GTP, 10 mMU T P ,0 . 2mM a
P32UTP
(3,000 Ci/mmol), 40 units of RNase OUTTM (Invitrogen) and
2.5 ml of a transcription-competent mitochondrial extract from
HeLa cells that was prepared as described previously [21]. After
30 min at 30uC, reactions were stopped by adding 200 mlo fs t o p
buffer (10 mM Tris-Cl, pH 8.0, 0.2 M NaCl, and 1 mM
EDTA). Samples were treated with 0.5% SDS and 100 mg/ml
proteinase K for 45 min at 42uC and precipitated by adding
0.6 ml of ice-cold ethanol and 1 mgo fy e a s tt R N A( S i g m a ) .T h e
resulting RNA pellets were dissolved in 20 mlo fg e l - l o a d i n g
buffer (98% formamide, 10 mM EDTA, pH 8.0, 0.025% xylene
cyanol, 0.025% bromphenol blue), heated to 95uC for 5 min,
and then separated on 6% polyacrylamide/7 M urea gels in 16
TBE buffer. Radiolabeled 10-bp ladder DNA (Invitrogen) was
run in parallel as a marker to estimate RNA transcript sizes. Gels
were dried and exposed to x-ray film at 280uC. The
experiments were repeated 3 times.
Databases
Human genetic variants were screened within experimentally
established protein binding sites and regulatory regions in the
mtDNA control region (Table 1). Specific nucleotide positions of
the variants were retrieved from the ‘‘Human Mitochondrial
Genome Database’’ (mtDB) (www.genpat.uu.se/mtDB), which
includes more than 2500 whole mtDNA sequences, representing
human populations worldwide. To assign control region variants
to specific branches in the human mtDNA phylogeny, sequences
containing genetic variants in the screened regulatory elements
were compared to the revised Cambridge Reference Sequence
[30]. Coding region variants in each of the retrieved sequences
were used to screen the global human mtDNA phylogenetic tree
that harbors worldwide human nucleotide variations, classified
into haplogroups and sub-haplogroups [31]. Since mtDNA is
transferred only through the maternal lineage and hence
recombination has (virtually) no effect, this procedure enabled us
to provide haplogroup assignments for mtDNAs harboring specific
control region variants of interest that were linked to haplogroup-
defining coding region mutations.
Estimating the number of mutation events
We used a phylogenetic approach relying on haplogroup
classification to determine the number of times that a mutation
event at a given nucleotide position had occurred during human
evolution. Such evaluation assumed that a group of sequences
belonging to the same phylogenetic branch (i.e. lineage or
haplogroup) represent one mutation event during human
evolution. For fixed mutations, we set a cut-off value. Changes
that were shared in 5 or more different mtDNA sequences
belonging to the same phylogenetic branch were considered fixed.
The reason for this cutoff value was, first, to avoid relatively recent
fixation events that have yet to be statistically established as the
number of whole mtDNA sequences increases. Secondly, branches
harboring 2–4 sequences gave relatively low bootstrap values in
the global mtDNA phylogenetic tree (data not shown). The
conservation of mitochondrial regulatory elements in mammals
was estimated using a multiple sequence alignment program
[(MEME), http://meme.sdsc.edu/meme/intro.html]. The num-
ber of times that a mutation event occurred during the
mammalian evolution was assessed using available phylogenetic
trees (one for mammals and another tree for primates) [32,33],
assuming that mutations shared by members of the same tree
branch had only occurred once in the ancestor of this branch.
Lymphoblast cytoplasmic hybrids (cybrid) generation
The Wal2A rho zero nuclear donor cell line, which had been
cured of its resident mtDNAs with ethidium bromide treatment
[34], was fused to chemically enucleated lymphoblasts containing
either haplogroup J or H mtDNA [35]. Donor lympho-
blasts,1.5610
6 , were pre-treated with 0.5 mg/ml actinomycin D
for 20 hours, the cells combined with 1.5610
6 Wal2A rho zero
cells, and fused using a pH-balanced PEG-1450 mixture for
60 seconds. Cells were allowed a 5 day post-fusion recovery period
in rho zero growth medium and then selected in a 1 mg/ml 6-
thioguanine-supplemented DMEM medium containing 10%
dialyzed serum solution for selection. Media were replaced every
4 days or when the media looked depleted until such time as the
cells achieved normal growth rates, as determined by periodic cell
counts. The cybrids were haplotyped post-fusion to determine
successful transfer of the mtDNA. The presence of Wal2a nuclear
background was confirmed by microsatellite testing and compar-
ison to the original lymphoblast and Wal2A microsatellite
identities. The haplogroup assignment of the cybrid clones was
determined using haplogroup specific polymorphisms and by
sequencing of the mtDNA control region [31].
Table 2. List of double-stranded oligonucleotides containing the mtDNA TFAM-binding sites.
Name of the oligonucleotides mtDNA nucleotide positions Sequences
Wild type (CRS) 233–260 59TAATAATAACAATTGAATGTCTGCACAG 39
39ATTATTATTGTTAACTTACAGACGTGTC 59
C242T–VAR (J1b) 233–260 59TAATAATAATAATTGAATGTCTGCACAG 39
39ATTATTATTATTAACTTACAGACGTGTC 59
Wild type (CRS) 276–303 59ACATCATAACAAAAAATTTCCACCAAAC 39
39TGTAGTATTGTTTTTTAAAGGTGGTTTG 59
C295T-VAR (J) 276–303 59ACATCATAACAAAAAATTTTCACCAAAC 39
39TGTAGTATTGTTTTTTAAAAGTGGTTTG 59
Variants within two of the TFAM-binding sites (position 233–260 and 276–303) are underlined in bold. Type of mtDNA genetic background is shown in parentheses in
the first column.
doi:10.1371/journal.pgen.1000474.t002
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in cybrids
mtDNA transcript levels were determined for each of the
cybrids by PCR incorporation of SYBR Green dye into real time
PCR products. The rate of dye incorporation was monitored using
the Roche LightCycler 480 real-time PCR system. Target genes
were normalized according to three reference gene products,
namely GAPDH, b-Actin and b2-Microglobulin [36,37]. The
geometric mean of the reference genes CTs was used for
normalization of transcript expression levels. Primers for the real
time PCR reactions were designed using the Primer 3 software
(Table 3). Four micro-liters of 56SYBR Green PCR Master Mix
(Roche) was mixed with 20 ng purified total RNA, 0.4 mMo f
gene-specific primers and ultra pure H2Oi na2 0ml reaction
volume within 384-well plates (Genesee Scientific and Roche). For
amplification, reaction mixtures were incubated for 2 min at 50uC
and 10 min at 95uC, followed by 45 cycles of three-steps consisting
of 15 seconds at 95uC, 20 seconds at 60uC and 15 seconds at
72uC. Following the PCR step, samples were heated from 60uCt o
95uC with a ramp time of 20 min to construct dissociation curves
and verify that single PCR products were obtained. PCR products
were also analyzed by gel electrophoresis to confirm primer
specificity. Serial cDNA dilutions were used for primer validation
experiments to demonstrate that both target and reference genes
had equal amplification efficiencies, according to the standard
curve method. The comparative CT method was used for relative
quantification of gene expression as described by the real time
PCR machine manual. Differences in the CT values (dCT) of the
transcript of interest and reference genes were used to determine
the relative expression of the gene in each sample. The dCT
method was used to calculate fold expression. Experiments were
carried out in triplicate for each data point. Roche analysis
software versions 2.1 (Applied Biosystems) and Microsoft Excel
were used for data analysis.
Assessment of mtDNA copy numbers in cybrids
mtDNA copy number calculations were performed by comparing
the ratio of the mtDNA-encoded ND2 gene levels to the nuclear
DNA-encoded 18S rRNA gene using real time quantitative PCR
amplification (Roche LC480) in three independent experiments per
tested DNA. To quantify each gene product, serial 106dilutions of
known cloned PCR fragments were used to create a standard curve.
CT values of the ND2 and 18S rRNA genes were plotted against this
standard curve to provide an absolute copy number level for each
gene. The ND2 to 18S rRNA ratios were then calculated for each of
thecybridDNAs.PrimersusedforamplificationoftheND2and18S
rRNA genes are listed in Table 3.
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